MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development.
Wu L, Bai X, Xie Y, Yang Z, Yang X, Lin J, Zhu C, Wang A, Zhang H, Miao R, Wu Y, Robson SC, Zhao Y, Sang X, Zhao H.
Wu L, et al. Among authors: lin j.
Hepatol Res. 2017 Jan;47(1):80-94. doi: 10.1111/hepr.12737. Epub 2016 Jul 13.
Hepatol Res. 2017.
PMID: 27138942
Review.